SIGA stock: Q2 revenue reached USD 41.00 million. SIGA stock is valued at USD 224.20 million

Published on 10/24/2026 at 04:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 41.00 million. SIGA stock is valued at USD 224.20 million with USD 118.00 million cash.

Cash balance and filing date

SIGA reported USD 41.00 million in second-quarter revenue in 2026.
The company held USD 118.00 million in cash on June 30, 2026.
SIGA targets an FDA filing in the first half of 2027.

SIGA, US8269171067, Illustration mit AI erstellt.

SIGA Technologies (ISIN US8269171067) reported USD 41.00 million in revenue for the second quarter of 2026, according to MarketBeat. SIGA had a market capitalization of USD 224.20 million as of October 23, 2026, while its last Nasdaq price was USD 3.12 at 4:00 p.m. EDT on that date.

Revenue depends on deliveries

The second-quarter figure reflected a concentrated delivery cycle. Benzinga reported that product-related revenue reached USD 38.00 million, including USD 24.00 million from intravenous TPOXX deliveries to the U.S. Strategic National Stockpile and USD 13.00 million from international sales.

The operating pattern matters because the final product order under SIGA's 19C contract was fulfilled in the second quarter. Management said discussions on a new multi-year U.S. procurement contract were continuing, while the timing of government purchases can shift revenue between quarters.

What does the pipeline mean?

The company held USD 118.00 million in cash and USD 0.00 in debt as of June 30, 2026. The same call reported USD 12.00 million in net income for the second quarter and diluted earnings per share of USD 0.17. Those figures give SIGA financial capacity while it works to broaden TPOXX demand.

Three dated operating markers

On August 6, 2026, SIGA reported its second-quarter results, including USD 38.00 million in product-related revenue. On October 12, 2026, Benzinga published the earnings-call transcript, which detailed the USD 24.00 million stockpile delivery and the USD 13.00 million international sales. On October 23, 2026, SIGA's market capitalization stood at USD 224.20 million and its Nasdaq price was USD 3.12.

Reporting date ahead

Barron's lists November 5, 2026 as a future SIGA reporting date. Management also targets an FDA submission for the post-exposure prophylaxis program in the first half of 2027, according to the earnings call.

Stock remains tied to contracts

SIGA's investment case combines a cash-rich balance sheet with uneven government procurement. The next material data point is whether new orders can replace the completed 19C contract and reduce the quarter-to-quarter swings in product revenue. On Nasdaq, SIGA was last at USD 3.12 on October 23, 2026 at 4:00 p.m. EDT.